Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization

Laboratory Investigation

Volumn 74, Issue 1, 1996, Pages 108-119

  Weber, Ruthild G ^a   Sommer, Clemens ^a   Albert, Friedrich K ^a   Kiessling, Marika ^a   Cremer, Thomas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER RADIOTHERAPY; CANCER SURGERY; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; DNA HYBRIDIZATION; GENE AMPLIFICATION; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; BRAIN NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA, NEOPLASM; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION;

EID: 0030034263     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Ahmed Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, and Bigner SH (1994). Alterations of the TP53 gene in human gliomas. Cancer Res 54:1324-1330.
2. Albert FK, Forsting M, Sartor K, Adams H-P, and Kunze S (1994). Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45-61.
3. Bigner SH, Mark J, Burger PC, Mahaley MS, Bullard DE, Muhlbaier LH, and Bigner DD (1988a). Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48: 405-411.
4. Bigner SH, Burger PC, Wong AJ Werner MH, Hamilton SR, Muhlbaier LH, Vogelstein B, and Bigner DD (1988b). Gene amplification in malignant human gliomas: Clinical and histopathological aspects. J Neuropathol Exp Neurol 47:191-205.
5. Black RA, Kronheim SR, and Sleath PR (1989). Activation of interleukin-1 beta by a co-induced protease. FEBS Lett 247:386-390.
6. Bottaro DP, Rubin JS, Faletto DL, Chan AML, Kmiecik TE, Vande Woude GF, and Aaronson SA (1991). Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science 251:802-804.
7. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, and Cannizzaro LA (1992). Molecular cloning of the interleukin-1 beta converting enzyme. Science 256:97-100.
8. Cozzolino F, Rubartelli A, Aldinucci D, Sitia R, Torcia M, Shaw A, and di Guglielmo R (1989). Interleukin-1 as an autocrine growth factor for acute myeloid leukemia cells. Proc Natl Acad Sci USA 86:2369-2373.
9. Du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, and Cremer T (1993). Detection of complete and partial chromosome gains and losses by comparative genomic hybridization. Hum Genet 90:590-610.
10. Du Manoir S, Schröck E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, and Cremer T (1995). Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41.
11. Fukuyama R, Ichijoh Y, Minoshima S, Kitamura N, and Shimizu N (1991). Assignment of hepatocyte growth factor (HGF) gene to chromosome 7q21.1. Cytogenet Cell Genet 58:1921.
12. Fuller G and Bigner SH (1992). Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res 276:299-306.
13. Fults D, Pedone CA, Thomas GA, and White R (1990). Allelotype of human malignant astrocytoma. Cancer Res 50:5784-5789.
14. Fults D and Pedone C. (1993) Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosom Cancer. 7:173-177.
15. Gaudray P, Szepetowski P, Escot C, Birnbaum D, and Theillet C (1992). DNA amplification at 11q13 in human cancer: From complexity to perplexity. Mutat Res 276:317-328.
16. Hunter SB, Abbott K, Varma VA, Olson JJ, Barnett DW, and James CD (1995). Reliability of differential PCR for the detection of EGFR and MDM 2 gene amplification in DNA extracted from FFPE glioma tissue. J Neuropathol Exp Neurol 54:57-64.
17. Hurtt MR, Moossy J, Donovan-Peluso M, and Locker J (1992). Amplification of epidermal growth factor receptor gene in gliomas: Histopathology and prognosis. J Neuropathol Exp Neurol 51:84-90.
18. Isola J, DeVries S, Chu L, Ghazvini S, and Waldman F (1994). Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145:1301-1308.
19. Jankowski SA, Mitchell DS, Smith SH, Trent JM, and Meltzer PS (1994). SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene 9:1205-1211.
20. Jenkins RB, Kimmel DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, and Dewald GW (1989). A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39:253-279.
21. Joos S, Schertan H, Speicher MR, Schlegel J, Cremer T, and Lichter P (1993). Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe. Hum Genet 90:584-589.
22. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, and Pinkel D (1992). Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
23. Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VP, Nordenskjöld M, and Larsson C (1993). Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 92:169-174.
24. Kim DH, Mohapatra G, Bollen A, Waldman FM, and Feuerstein BG (1995). Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer 60:812-819.
25. Kleihues P, Burger PC, and Scheithauer BW (1993). Histological typing of tumours of the central nervous system. Berlin: Springer, 11-14.
26. Lang FF, Miller DC, Koslow M, and Newcomb EW (1994). Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81:427-436.
27. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, and Schlessinger J (1985). Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313:144-147.
28. Lichter P and Cremer T (1992). Chromosome analysis by nonisotopic in situ hybridization. In: Rooney DE, Czepulkowski BH, editors. Human cytogenetics, vol. 1. A practical approach, 2nd ed. New York: Oxford University Press 157-192.
29. Mahaley MS, Mettlin C, Natarajan N, Laws ER, and Peace BB (1989). National survey of patterns of care for brain-tumor patients. J Neurosurg 71:826-836.
30. Maniatis T, Fritsch EF, and Sambrook J (1982). Molecular cloning. A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory.
31. Mitelman F (1994). Catalog of chromosome aberrations in cancer, 5th ed. New York: Wiley-Liss, Inc.
32. Mitelman F, editor (1995). ISCN: An international system for human cytogenetic nomenclature. Basel: S. Karger.
33. Momand J, Zambetti GP, Olson DC, George D, and Levine AJ (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
34. Muleris M, Almeida A, Dutrillaux AM, Pruchon E, Vega F, Delattre JY, Poisson M, Malfoy B, and Dutrillaux B (1994). Oncogene amplification in human gliomas: A molecular cytogenetic analysis. Oncogene 9:2717-2722.
35. Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, Michalopoulos GK, Birchmeier W, and Comoglio PM (1991). Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10:2865-2878.
36. Neel BG, Jhanwar SC, Chaganti RSK, and Hayward WS (1982). Two human c-onc genes are located on the long arm of chromosome 8. Proc Natl Acad Sci USA 79:7842-7846.
37. Nigro JM, Baker SJ, Jessup JM, Hostetter R, Bigner SH, Devilee P, Glover T, Westin A, Harris C, and Vogelstein B (1989). p53 gene mutations occur in diverse tumor types. Nature 342:705-708.
38. Oliner JD, Kinzler KW, Meltzer PS, George DL, and Vogelstein B (1992). Amplification of a gene encoding a p53-associated protein in human sarcoma. Nature 358:80-83.
39. Pinkel D, Straume T, and Gray JW (1986). Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83:2934-2938.
40. Piper J, Rutovitz D, Sudar D, Kallioniemi A, Kallioniemi OP, Waldman FM, Gray JW, and Pinkel D (1995). Computer image analysis of comparative genomic hybridization. Cytometry 19:10-26.
41. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, and Collins VP (1994). Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows differential involvement of CDK4, SAS and MDM2. Cancer Res 54: 4299-4303.
42. Saccone S, Narsimhan RP, Gaudino G, Dalpra L, Comoglio PM, and Delia Valle G (1992). Regional mapping of the human hepatocyte growth factor (HGF)-scatter factor gene to chromosome 7q21.1. Genomics 13:912-914.
43. Schlegel J, Merdes A, Stumm G, Albert FK, Forsting M, Hynes N, and Kiessling M (1994). Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 56:72-77.
44. Schröck E, Thiel G, Losanowa T, du Manoir S, Meffert M-C, Jauch A, Speicher MR, Nürnberg P, Vogel S, Jänisch W, Donis-Keller H, Ried T, Witkowski R, and Cremer T (1994). Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144:1203-1218.
45. 1 cyclins. Cell 73:1059-1065.
46. Speicher MR, du Manoir S, Schröck E, Holtgreve-Grez H, Schoell B, Lengauer C, Cremer T, and Ried T (1993). Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification. Hum Mol Genet 2:1907-1914.
47. Speicher MR, Jauch A, Walt H, du Manoir S, Ried T, Jochum W, Sulser T, and Cremer T (1995). Correlation of microscopic phenotype with genotype in a formalin-fixed, paraffin-embedded testicular germ cell tumor with universal DNA amplification, comparative genomic hybridization, and interphase cytogenetics. Am J Pathol 146:1332-1340.
48. Steck PA, Ligon AH, Cheong P, Yung WKA, and Pershouse MA (1995). Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosom Cancer 12:255-261.
49. Thiel G, Losanowa T, Kintzel D, Nisch G, Martin H, Vorpahl K, and Witkowski R (1992). Karyotypes in 90 human gliomas. Cancer Genet Cytogenet 58:109-120.
50. Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, Mashal R, Feinberg A, and Vogelstein B (1986). Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83:470-473.
51. Venter DJ, Bevan KL, Ludwig RL, Riley TEW, Jat PS, Thomas DGT, and Noble MD (1991). Retinoblastoma gene deletions in human glioblastomas. Oncogene 6:445-448.
52. Von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, and Louis DN (1993). Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3:19-26.
53. Wullich B, Sattler HP, Fischer U, and Meese E (1994). Two independent amplification events on chromosome 7 in glioma: Amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Anticancer Res 14:577-580.
54. Zülch KG (1979). Histological typing of tumors of the central nervous system. In: International Histological Classification of Tumors, vol. 21. Geneva: World Health Organization.